Sofinnova Venture Partners XI, L.P. - 11 Sep 2025 SCHEDULE 13D/A Report for Rapport Therapeutics, Inc. Common Stock, $0.001 par value (RAPP)

Filing Manager
Sofinnova Venture Partners XI, L.P.
Reporting Manager
Dr. James I. Healy ("Healy")
Security
Rapport Therapeutics, Inc. Common Stock, $0.001 par value
Symbol
RAPP
Shares outstanding
46,370,929 shares
Disclosed Ownership
1,947,579 shares
Ownership
4.2%
Form type
SCHEDULE 13D/A
Filing time
18 Sep 2025, 17:32:20 UTC
Date of event
11 Sep 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Sofinnova Venture Partners XI, L.P. ("SVP XI") 4% 1,863,327 1,863,327 0 /s/ Nathalie Auber Nathalie Auber/Attorney-in-Fact 0001882303
Sofinnova Management XI, L.P. ("SM XI LP") 4% 1,863,327 1,863,327 0 /s/ Nathalie Auber Nathalie Auber/Attorney-in-Fact
Sofinnova Management XI, L.L.C. ("SM XI LLC") 4% 1,863,327 1,863,327 0 /s/ Nathalie Auber Nathalie Auber/Attorney-in-Fact
Dr. James I. Healy ("Healy") 4.2% 1,947,579 4,822 1,947,579 /s/ Nathalie Auber Nathalie Auber/Attorney-in-Fact
Dr. Maha Katabi ("Katabi") 4% 1,863,327 0 1,863,327 /s/ Nathalie Auber Nathalie Auber/Attorney-in-Fact